HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Hu Zhu Selected Research

Messenger RNA (mRNA)

9/2013Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?
2/2007[Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Hu Zhu Research Topics

Disease

24Acute Promyelocytic Leukemia
11/2023 - 02/2007
22Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 07/2006
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 07/2006
6Neoplasms (Cancer)
03/2023 - 12/2013
5Philadelphia Chromosome
12/2024 - 01/2020
5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2024 - 01/2020
4Leukemia
01/2020 - 05/2016
4Residual Neoplasm
01/2019 - 02/2012
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 06/2003
3Leukocytosis (Pleocytosis)
11/2022 - 10/2017
3Infections
08/2022 - 11/2013
3Hematologic Neoplasms (Hematological Malignancy)
05/2022 - 04/2016
3Thrombocytopenia (Thrombopenia)
01/2018 - 10/2015
2Fever (Fevers)
08/2022 - 11/2013
2Melanoma (Melanoma, Malignant)
12/2017 - 04/2017
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2013 - 07/2006
1Bites and Stings (Sting)
12/2024
1Carcinogenesis
05/2022
1Hyperthermia
07/2021
1Dyslipidemias (Dyslipidemia)
01/2020
1Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
01/2020
1Disseminated Intravascular Coagulation
01/2018
1Multiple Myeloma
12/2017
1Testicular Neoplasms (Testicular Cancer)
12/2017
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017
1Wilms Tumor (Wilm's Tumor)
05/2016
1Hemorrhage
02/2007

Drug/Important Bio-Agent (IBA)

16ArsenicIBA
10/2022 - 08/2013
14Arsenic Trioxide (Trisenox)FDA Link
11/2022 - 11/2013
14Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2022 - 08/2013
6venetoclaxIBA
03/2024 - 01/2020
5Cytarabine (Cytosar-U)FDA LinkGeneric
03/2024 - 11/2013
4AclarubicinIBA
01/2020 - 11/2013
3Proteins (Proteins, Gene)FDA Link
03/2023 - 07/2006
3Oncogene Proteins (Oncogene Protein)IBA
05/2022 - 11/2016
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 11/2013
3realgar-indigo naturalisIBA
01/2018 - 11/2013
3AntigensIBA
12/2017 - 06/2003
2Chimeric Antigen ReceptorsIBA
12/2024 - 03/2023
2Tyrosine Kinase InhibitorsIBA
01/2023 - 09/2013
2Hemoglobins (Hemoglobin)IBA
08/2022 - 02/2007
2Prednisone (Sone)FDA LinkGeneric
01/2022 - 01/2020
2LipidsIBA
01/2020 - 01/2020
2HomoharringtonineIBA
11/2016 - 05/2016
2Imatinib Mesylate (Gleevec)FDA Link
01/2016 - 09/2013
2Messenger RNA (mRNA)IBA
09/2013 - 02/2007
1Bispecific AntibodiesIBA
12/2024
1Transcription Factors (Transcription Factor)IBA
04/2024
1Daunorubicin (Cerubidine)FDA LinkGeneric
03/2024
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
11/2023
1nelarabine (506U78)FDA Link
03/2023
1blinatumomabIBA
01/2023
1Hydroxyurea (Hydrea)FDA LinkGeneric
11/2022
1DecitabineFDA Link
08/2022
1Azacitidine (5 Azacytidine)FDA Link
08/2022
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
05/2022
1ponatinibIBA
01/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
07/2021
1Co-Repressor ProteinsIBA
07/2021
1UbiquitinIBA
07/2021
1Drug CombinationsIBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021
1LeptinIBA
01/2020
1Dasatinib (BMS 354825)FDA Link
01/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2020
1ResistinIBA
01/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2019
1Insulin-Like Growth Factor Binding Protein 3IBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Dacarbazine (DIC)FDA LinkGeneric
01/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018
1Alanine Transaminase (SGPT)IBA
01/2018
1Bortezomib (Velcade)FDA Link
12/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2016
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
04/2016
1Core Binding Factors (Core-Binding Factor)IBA
12/2014
1Sulfides (Thioethers)IBA
11/2013
1Transaminases (Aminotransferases)IBA
11/2013
1NucleophosminIBA
07/2013
1promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
02/2007
1PhosphotyrosineIBA
07/2006
1CytokinesIBA
06/2003

Therapy/Procedure

16Drug Therapy (Chemotherapy)
12/2024 - 06/2012
12Therapeutics
12/2024 - 05/2013
7Hematopoietic Stem Cell Transplantation
01/2023 - 02/2012
2CAG protocol
01/2020 - 11/2013
1Immunotherapy
12/2024
1Transplantation
01/2020
1Haploidentical Transplantation
01/2019
1Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2016
1Consolidation Chemotherapy
05/2016
1Induction Chemotherapy
11/2013
1Stem Cell Transplantation
06/2012